Large-Cell Lymphoma

The Lymphomas

Volumn , Issue , 2006, Pages 295-324

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34250833289     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0081-9.50021-2     Document Type: Chapter

References (234)

1. JO Armitage and DD Weisenburger (1998) New approach to classi-fying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 16 2780-2795.
2. RT Greenlee, MB Hill-Harmon, T Murray, et al. (2001) Cancer statis-tics, 2001. CA Cancer J Clin 51 15-36.
3. PP Carbone, HS Kaplan, K Musshoff, et al. (1971) Report of the Com-mittee on Hodgkin's Disease Staging Classification. Cancer Res 31 1860-1861.
4. RI Fisher, SM Hubbard, VT DeVita, et al. (1981) Factors predicting long-term survival in diffuse mixed, histiocytic, or undiffer-entiated lymphoma. Blood 58 45-51.
5. RI Fisher, VT DeVita Jr, BL Johnson, et al. (1977) Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy. Am J Med 63 177-182.
6. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329 987-994.
7. TP Miller, TM Grogan, S Dahlberg, et al. (1994) Prognostic signifi-cance of the Ki-67-associated proliferative antigen in aggres-sive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial. Blood 83 1460-1466.
8. SL Barrans, I Carter, RG Owen, et al. (2002) Germinal center phe-notype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma. Blood 99 1136-1143.
9. RD Gascoyne, SA Adomat, S Krajewski, et al. (1997) Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lym-phoma. Blood 90 244-251.
10. N Mounier, J Briere, C Gisselbrecht, et al. (2003) Rituximab plus CHOP (R-CHOP) overcomes bcl-2-associated resistance to chemotherapy in elderly patients with diffuse large B-cell lym-phoma (DLBCL). Blood 101 4279-4284.
11. K Offit, F LoCoco, DC Louie, et al. (1994) Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lym-phoma. N Engl J Med 331 74-80.
12. IS Lossos, CD Jones, R Warnke, et al. (2001) Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. Blood 98 945-951.
13. A Rosenwald, G Wright, WC Chan, et al. (2002) The use of molecu-lar profiling to predict survival after chemotherapy for diffuse large B-cell lymphoma. N Engl J Med 346 1937-1947.
14. MA Shipp, KN Ross, P Tamayo, et al. (2002) Diffuse large B-cell lym-phoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 8 68-74.
15. IS Lossos, DK Czerwinski, AA Alizadeh, et al. (2004) Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med 350 1828-1837.
16. LM Staudt (2003) Molecular diagnosis of the hematologic cancers. N Engl J Med 348 1777-1785.
17. BH Mavromatis and BD Cheson (2002) Pre- and post-treatment evaluation of non-Hodgkin's lymphoma. Best Pract Res Clin Haematol 15 429-447.
18. JW Friedberg and V Chengazi (2003) PET scans in the staging of lymphoma: current status. Oncologist 8 438-447.
19. L Kostakoglu, JP Leonard, I Kuji, et al. (2002) Comparison of fluo-rine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma. Cancer 94 879-888.
20. DE Hallahan, R Farah, EE Vokes, et al. (1989) The patterns of failure in patients with pathological Stage I and II diffuse histiocytic lymphoma treated with radiation therapy alone. Int J Radiat Oncol Biol Phys 17 767-771.
21. TP Miller, S Dahlberg, JR Cassady, et al. (1998) Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med 339 21-26.
22. S Horning, J Glick, et al. (2001) Final report of E1484: CHOP v CHOP + radiotherapy for limited stage diffuse aggressive lym-phoma. Blood 98 724a.
23. G Fillet and C Bonnet (2002) Radiotherapy is unnecessary in elderly patients with localized aggressive non-Hodgkin's lymphoma: results of the GELA LNH 93-4 study. Blood 100 92a.
24. F Reyes, E Lepage, JN Munck, et al. (2002) Superiority of chemother-apy alone with the ACVBP regimen over treatment with three cycles of CHOP plus radiotherapy in low risk localized aggressive lymphoma: The LNH93-1 GELA study. Blood 100 93a.
25. VT DeVita, GP Canellos, B Chabner, et al. (1975) Advanced diffuse histiocytic lymphoma, a potentially curable disease. Lancet 1 248-250.
26. SE Jones, PN Grozea, EN Metz, et al. (1979) Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma: a Southwest Oncology Group study. Cancer 43 417-425.
27. SE Jones, PN Grozea, EN Metz, et al. (1983) Improved complete remission rates and survival for patients with large cell lymphoma treated with chemoimmunotherapy: a Southwest Oncology Group Study. Cancer 51 1083-1090.
28. SE Jones, PN Grozea, TP Miller, et al. (1985) Chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone alone or with levamisole or with levamisole plus bcg for malignant lymphoma: a Southwest Oncology Group Study. J Clin Oncol 3 1318-1324.
29. CA Coltman, S Dahlberg, SE Jones, et al. (1988) Southwest Oncology Group studies in diffuse large cell lymphoma: a subset analysis. K Kimura (Eds) Cancer Chemotherapy: Challenges for the Future Tokyo: Excerpta Medica 194-202.
30. LI Gordon, D Harrington, J Andersen, et al. (1992) Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma. N Engl J Med 327 1342-1349.
31. IA Cooper, MM Wolf, TI Robertson, et al. (1994) Randomized comparison of MACOP-B and CHOP in patients with inter-mediate grade non-Hodgkin's lymphoma. J Clin Oncol 12 769-778.
32. RI Fisher, ER Gaynor, S Dahlberg, et al. (1993) Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 328 1002-1006.
33. JM Vose, BK Link, ML Grossbard, et al. (2001) Phase II study of rit-uximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lym-phoma. J Clin Oncol 19 389-397.
34. B Coiffier, E Lepage, J Briere, et al. (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346 235-242.
35. MS Czuczman, AJ Grillo-Lopez, CA White, et al. (1999) Treatment of patients with low-grade B-cell lymphoma with the com-bination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy. J Clin Oncol 17 268-276.
36. TM Haberman, EA Weller, VA Morrison, et al. (2003) Phase III trial of rituximab-CHOP vs. CHOP with a second randomization to maintenance rituximab or observation in patients 60 years of age and older with diffuse large B cell lymphoma. Blood 102 6a.
37. MG Pfreundschuh, L Truemper, D Ma, et al. (2004) Randomized intergroup trial of first line treatment of patients <= 60 years with diffuse large B cell non-Hodgkin's lympohma with a CHOP-like regimen with or without the anti-CD20 antibody rituximab—early stopping after the first interim analysis. Proc ASCO 23 556a.
38. DW Blayney, ML LeBlanc, T Grogan, et al. (2003) Dose-intense chemotherapy every 2 weeks with dose-intense cyclophos-phamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: a Phase II study of the Southwest Oncology Group (SWOG 9349). J Clin Oncol 21 2466-2473.
39. M Pfreundschuh, L Truemper, M Kloess, et al. (2004) 2-Weekly or 3- weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL. Blood 104(3), 626-633.
40. M Pfreundschuh, L Truemper, M Kloess, et al. (2004) 2-Weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lym-phomas: results of the NHL-B2 trial of the DSHNHL. Blood 104 626-633.
41. T Philip, C Guglielmi, A Hagenbeek, et al. (1995) Autologous bone marrow transplantation as compared with salvage chemother-apy in relapses of chemotherapy-sensitive non-Hodgkin's lym-phoma. N Engl J Med 333 1540-1545.
42. RI Fisher (2002) Autologous stem-cell transplantation as a compo-nent of initial treatment for poor risk patients with aggressive non-Hodgkin's lymphoma: resolved issues versus remaining opportunities. J Clin Oncol 20 4411-4412.
43. AM Gianni, M Bregni, S Siena, et al. (1997) High dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med 336 1290-1297.
44. C Haioun, E Lepage, C Gisselbrecht, et al. (2000) Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lym-phoma. Final analysis of the Prospective LNH87-2 Protocol— A Groupe d'Etude des Lymphomes de l'Adulte Study. J Clin Oncol 18 3025-3030.
45. M Martelli, F Gherlinzoni, A De Renzo, et al. (2003) Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial. J Clin Oncol 21 1255-1262.
46. N Milpied, E Deconinck, F Gaillard, et al. (2004) Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. N Engl J Med 350 1287-1295.
47. C Haioun, E Lepage, C Gisselbrecht, et al. (1994) Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 12 2543-2551.
48. G Santini, L Salvagno, P Leoni, et al. (1998) VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective ran-domized trial by the non-Hodgkin's Lymphoma Cooperative Study Group. J Clin Oncol 16 2796-2802.
49. MA Shipp, MD Abeloff, KH Antman, et al. (1999) International consensus conference on high-dose therapy with hematopoi-etic stem cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury. J Clin Oncol 17 423-429.
50. B Coiffier, C Haioun, N Ketterer, et al. (1998) Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter Phase II study. Blood 92 1927-1932.
51. T Kewalramani, AD Zelenetz, SD Nimer, et al. (2004) Rituximab and ICE as second-line therapy before autologous stem cell trans-plantation for relapsed or primary refractory diffuse large B-cell lymphoma. Blood 103 3684-3688.
52. CH Moskowitz, JR Bertino, JR Glassman, et al. (1999) Ifosfamide, car-boplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progrenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma. J Clin Oncol 17 3776-3785.
53. JW Friedberg, D Neuberg, E Monson, et al. (2001) The impact of external beam radiation therapy prior to autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma. Biol Blood Marrow Transplant 7 446-453.
54. AK Lichtenstein, A Levine, CR Taylor, et al. (1980) Primary mediastinal lymphoma in adults. Am J Med 68 509-514.
55. LJ Levitt, AC Aisenberg, NL Harris, et al. (1982) Primary non-Hodgkin's lymphoma of the mediastinum. Cancer 50 2486-2492.
56. NL Harris, ES Jaffe, H Stein, et al. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84 1361-1392.
57. ES Jaffe, NL Harris, H Stein, et al. (2001) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues Lyon: IARC Press
58. D Cazals-Hatem, E Lepage, P Brice, et al. (1996) Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA (“Groupe d'Etude des Lymphomes de l'Adulte”) study. Am J Surg Pathol 20 877-888.
59. B Falini, S Venturi, M Martelli, et al. (1995) Mediastinal large B-cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third-generation regimens. Br J Haematol 89 780-789.
60. P Moller, B Lammler, M Eberlein-Gonska, et al. (1986) Primary mediastinal clear cell lymphoma of B-cell type. Virchows Arch A Pathol Anat Histopathol 409 79-92.
61. L de Leval, JA Ferry, B Falini, et al. (2001) Expression of bcl-6 and CD10 in primary mediastinal large B-cell lymphoma: evidence for derivation from germinal center B cells? Am J Surg Pathol 25 1277-1282.
62. A Scarpa, F Bonetti and F Menestrina (1987) Mediastinal large cell lymphoma with sclerosis. Genotypic analysis establishes its B nature. Virchows Arch A Pathol Anat Histopathol 412 17-21.
63. P Tsang, E Cesarman, A Chadburn, et al. (1996) Molecular charac-terization of primary mediastinal B cell lymphoma. Am J Pathol 148 2017-2025.
64. S Joos, MI Otano-Joos, S Ziegler, et al. (1996) Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood 87 1571-1578.
65. A Rosenwald, G Wright, K Leroy, et al. (2003) Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 198 851-862.
66. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 89 3909-3918.
67. L Lamarre, J Jacobson, A Aisenberg, et al. (1989) Primary large cell lymphoma of the mediastinum. Am J Surg Pathol 13 730-739.
68. JO Jacobson, AC Aisenberg, L Lamarre, et al. (1988) Mediastinal large cell lymphoma: an uncommon subset of adult lymphoma curable with combined modality therapy. Cancer 62 1893-1898.
69. M Lazzarino, E Orlandi, M Paulli, et al. (1997) Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients. J Clin Oncol 15 1646-1653.
70. PL Zinzani, M Bendandi, G Frezza, et al. (1996) Primary mediastinal B-cell lymphoma with sclerosis: clinical and therapeutic evaluation of 22 patients. Leuk Lymphoma 21 311-316.
71. C Haioun, P Gaulard, F Roudot-Thoraval, et al. (1989) Mediastinal diffuse large B-cell lymphoma with sclerosis: a condition with a poor prognosis. Am J Clin Oncol 12 425-429.
72. M Lazzarino, E Orlandi, M Paulli, et al. (1993) Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathological features. J Clin Oncol 11 2306-2313.
73. P Bishop, W Wilson, D Pearson, et al. (1999) CNS involvement in primary mediastinal large B-cell lymphoma. J Clin Oncol 17 2479-2485.
74. AF Abrahamsen, HH Lien, M Aas, et al. (1994) Magnetic resonance imaging and 67gallium scan in mediastinal malignant lym-phoma: a prospective pilot study. Ann Oncol 5 433-436.
75. PL Zinzani, M Martelli, M Magagnoli, et al. (1999) Treatment and clinical management of primary mediastinal large B-cell lym-phoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67) gallium scan in 50 patients. Blood 94 3289-3293.
76. T Lavabre-Bertrand, D Donadio, N Fegueux, et al. (1992) A study of 15 cases of primary mediastinal lymphoma of B-cell type. Cancer 69 2561-2566.
77. AZ Rohatiner, JS Whelan, RK Ganjoo, et al. (1994) Mediastinal large-cell lymphoma with sclerosis (MLCLS). Br J Cancer 69 601-604.
78. M Bertini, L Orsucci, U Vitolo, et al. (1991) Stage II large B-cell lym-phoma with sclerosis treated with MACOP-B. Ann Oncol 2 733-737.
79. G Todeschini, A Ambrosetti, V Meneghini, et al. (1990) Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients. J Clin Oncol 8 804-808.
80. D Kirn, P Mauch, K Shaffer, et al. (1993) Large-cell and immunoblas-tic lymphoma of the mediastinum: prognostic and pathologic features in 57 patients. J Clin Oncol 11 1336-1343.
81. AC Aisenberg (1993) Primary large-cell lymphoma of the medi-astinum. J Clin Oncol 11 2291-2298.
82. J Rodriguez, WC Pugh, JE Romaguera, et al. (1994) Primary mediastinal large cell lymphoma. Haematol Oncol 12 175-184.
83. AA Abou-Elella, DD Weisenburger, JM Vose, et al. (1999) Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska lymphoma study group. J Clin Oncol 17 784-790.
84. T Perrone, G Frizzera and J Rosai (1986) Mediastinal diffuse large-cell lymphoma with sclerosis. A clinicopathologic study of 60 cases. Am J Clin Pathol 10 176-191.
85. M Al-Sharabati, S Chittal, I Duga-Neulet, et al. (1991) Primary ante-rior mediastinal B-cell lymphoma: a clinicopathological and immunohistochemical study of 16 cases. Cancer 67 2579-2583.
86. S Bieri, E Roggero, E Zucca, et al. (1999) Primary mediastinal large B-cell lymphoma (PMLCL): the need for prospective con-trolled clinical trials. Leuk Lymphoma 35 139-146.
87. LN Nguyen, CS Ha, M Hess, et al. (2000) The outcome of combined-modality treatments for Stage I and II primary large B-cell lymphoma of the mediastinum. Int J Radiat Oncol Biol Physi-cians 47 1281-1285.
88. MP Martelli, M Martelli, E Pescarmona, et al. (1998) MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosis. Ann Oncol 9 1027-1029.
89. PL Zinzani, M Martelli, A De Renzo, et al. (2001) Primary media-stinal large B-cell lymphoma with slerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy. Haematologica 86 187-191.
90. RI Fisher, ER Gaynor, S Dahlberg, et al. (1993) Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 329 1002-1006.
91. PL Zinzani, M Martelli, M Bertini, et al. (2002) Induction chemother-apy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study od 426 pre-viously untreated patients. Haematologica 87 1258-1264.
92. G Todeschini, S Secchi, E Morra, et al. (2004) Primary mediastinal laerge B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B. Br J Cancer 90 372-376.
93. A Nademanee, A Molina, M O'Donnell, et al. (1997) Results of high-dose therapy and autologous bone marrow/stem cell trans-plantation during remission in poor-risk intermediate and high-grade lymphoma: international index high and high-intermediate risk group. Blood 90 3844-3852.
94. U Popat, D Przepiork, R Champlin, et al. (1998) High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome. J Clin Oncol 16 63-69.
95. LH Sehn, JH Antin, LN Shulman, et al. (1998) Primary diffuse large B-cell lymphoma of the mediastinum. Outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation. Blood 91 717-723.
96. AC Aisenberg (1999) Primary large cell lymphoma of the mediastinum. Semin Oncol 26 251-258.
97. K Van Besien, M Kelta and P Bahaguna (2001) Primary mediastinal B-cell lymphoma: a review of pathology and management. J Clin Oncol 19 1855-1864.
98. W Bleyer and T Byrne (1988) Leptomeningeal cancer in leukemia and solid tumors. Curr Probl Cancer 12 181-238.
99. JW Hanbery and GS Dugger (1964) Perithelial sarcoma of the brain. A clinicopathologic study of thirteen cases. Arch Neurol Psychiatry 74 732-761.
100. LB Barnett and E Schwartz (1974) Cerebral reticulum cell sarcoma after multiple renal transplants. J Neurol Neurosurg Psychiatry 37 966-970.
101. L Benedek and A Juba (1941) Uber das Microgliom. Dtsch Z Nervehnheilk 152 159-163.
102. HH Schaumburg, CR Plank and RD Adams (1972) The reticulum cell sarcoma-microglioma group of brain tumors. Brain 95 199-212.
103. A Lister, LE Abrey and JT Sandlund (2002) Central nervous system lymphoma. Hematology (Am Soc Hematol Educ Program) 283-296.
104. C Freeman, JW Berg and SJ Cutler (1972) Occurrence and prognosis of extranodal lymphomas. Cancer 29 252-260.
105. K Jellinger, TH Radaskiewicz and F Slowik (1975) Primary malignant lymphomas of the central nervous system in man. Acta Neuropathol (Berl) 6(suppl), 95-102.
106. HM Zimmerman (1975) Malignant lymphomas of the nervous system. Acta Neuropathol (Berl) 6(suppl), 69-74.
107. MM Brand and VA Marinkovich (1969) Primary malignant reticulosis of the brain in Wiskott–Aldrich syndrome. Report of a case. Arch Dis Child 44 536-542.
108. LM Model (1977) Primary reticulum cell sarcoma of the brain in Wiskott-Aldrich syndrome. Report of a case. Arch Neurol 34 633-635.
109. P Littman and CC Wang (1975) Reticulum cell sarcoma of the brain: a review of the literature and a study of 19 cases. Cancer 35 1412-1420.
110. TL DeWeese, MB Hazuka, DJ Hommel, et al. (1991) AIDS-related non-Hodgkin's lymphoma: The outcome and efficacy of radiation therapy. Int J Radiat Oncol Biol Phys 20 803-808.
111. I Penn (1977) Development of cancer as a complication of clinical transplantation. Transplant Proc 9 1121-1127.
112. J Weintraub and RA Warnke (1982) Lymphoma in cardiac allotransplant recipients. Clinical and histological features and immunologic phenotypes. Transplantation 33 347-351.
113. KM Diette, WA Caro and HH Roenigk Jr (1984) Malignant lymphoma presenting with cutaneous granulomas. J Am Acad Dermatol 10 896-902.
114. AE Good, HR Russo, B Schnitzer, et al. (1978) Intracranial histiocytic lymphoma with rheumatoid arthritis. J Rheumatol 5 75-78.
115. EA Lipsmeyer (1972) Development of malignant cerebral lymphoma in a patient with systemic lupus erythematosus treated with immunosuppression. Arthritis Rheum 15 183-186.
116. WD Snider, DM Simpson, S Nielsen, et al. (1983) Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 14 403-418.
117. M Pluda, R Yarchoan, ES Jaffe, et al. (1990) Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy. Ann Intern Med 113 276-282.
118. NL Eby, S Grufferman, CM Flannelly, et al. (1988) Increasing incidence of primary brain lymphoma in the U.S. Cancer 62 2461-2465.
119. LM DeAngelis (1992) Primary central nervous system lymphoma. PPO Update 6 1-16.
120. D Hao, LM DiFrancesco, PM Brasher, et al. (1999) Is primary CNS lymphoma really becoming more common? A population-based study of incidence, clinicopathological features and outcomes in Alberta from 1975–1996. Ann Oncol 10 65-70.
121. SR Plotkin and TT Batchelor (2001) Primary nervous-system lymphoma. Lancet Oncol 2 354-365.
122. R Bashir, A Freedman, N Harris, et al. (1989) Immunophenotypic profile of CNS lymphoma: A review of eighteen cases. J Neurooncol 7 249-254.
123. TS Reese and MJ Karnovsky (1967) Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol 37 207-217.
124. DP Rall and CG Zubrod (1962) Mechanisms of drug absorption and excretion: Passage of drugs in and out of the central nervous system. Ann Rev Pharmacol 2 109-116.
125. JB Murphy and E Sturm (1923) Conditions determining the transplantability of tissues in the brain. J Exp Med 38 183-186.
126. PB Medawar (1948) Immunity to homologous grafted skin. The fate of skin homografts transplanted to the brain, to subcutaneous tissue and to the anterior chamber of the eye. Br J Exp Pathol 29 58-64.
127. HSN Greene (1957) Heterotransplantation of tumours. Ann N Y Acad Sci 69 818-829.
128. HL Weiner and SL Hauser (1982) Neuroimmunology. I. Immunoregulation in neurological disease. Ann Neurol 11 437-449.
129. HA Fine and RJ Mayer (1993) Primary central nervous system lymphoma. Ann Intern Med 119 1093-1104.
130. AM Levine (1992) Acquired immunodeficiency syndrome-related lymphoma. Blood 80 8-20.
131. FH Hochberg, G Miller and RT Schooley (1983) Central-nervous-system lymphoma related to Epstein–Barr virus. N Engl J Med 309 745-748.
132. RM Bashir, NL Harris, FH Hochberg, et al. (1989) Detection of Epstein–Barr virus in CNS lymphomas by in-situ hybridization. N Engl J Med 39 813-817.
133. M Ho, G Miller, RW Atchison, et al. (1985) Epstein–Barr virus infections and DNA hybridization studies in posttransplant lymphoma and lymphoproliferative lesions: The role of primary infection. J Infect Dis 152 876-886.
134. M Ho, R Jaffe, G Miller, et al. (1988) The frequency of Epstein–Barr virus infection and associative lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantion 45 719-727.
135. I Magrath (1985) Clinical and pathological features of Burkitt's lymphoma and their relevance to treatment. PH Levine, DV Ablash, GR Pearson, et al., (Eds) Epstein–Barr and Associated Diseases Boston: Martinus Nijhoff 631-643.
136. G Klein (1979) Lymphoma development in mice and human: diversity of inhibition is followed by convergent cytogenetic evaluation. Proc Natl Acad Sci U S A 76 2442-2446.
137. FH Hochberg and DC Miller (1988) Primary central nervous system lymphoma. J Neurosurg 68 835-853.
138. BP O'Neill and JJ Illig (1989) Primary central nervous system lymphoma. Mayo Clin Proc 64 1005-1020.
139. LM DeAngelis, J Yahalom, HT Thaler, et al. (1992) Combined modality therapy for primary CNS lymphoma. J Clin Oncol 10 635-643.
140. EA Neuwelt, EP Frenkel, MK Gumerlock, et al. (1986) Developments in the diagnosis and treatment of primary CNS lymphoma: a prospective series. Cancer 58 1609-1620.
141. KM Braaten, RA Betensky, L de Leval, et al. (2003) BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma. Clin Cancer Res 9 1063-1069.
142. TT Batchelor, G Kolak, R Ciordia, et al. (2003) High-dose methotrexate for intraocular lymphoma. Clin Cancer Res 9 711-715.
143. P O'Brien, D Roos, G Pratt, et al. (2000) Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma. J Clin Oncol 18 519-526.
144. LM DeAngelis, W Seiferheld, SC Schold, et al. (2002) Combination chemotherapy and radiotherapy for primary central nervous system lymphoma. Radiation Therapy Oncology Group Study 93–10. J Clin Oncol 20 4643-4648.
145. T Batchelor, K Carson, A O'Neill, et al. (2003) Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96–07. J Clin Oncol 21 1044-1049.
146. A Bioardi, A Silvani, A Pozzi, et al. (1999) Chemotherapy is effective as early treatment for primary central nervous system lymphoma. J Neurol 246 31-37.
147. S Ng, MA Rosenthal, D Ashley, et al. (2000) High-dose methotrexate for primary CNS lymphoma in the elderly. J Neurooncol 2 40-44.
148. LE Abrey, J Yahalom and LM DeAngelis (2000) Treatment of primary CNS lymphoma: the next step. J Clin Oncol 18 3144-3150.
149. U Herrlinger, M Schabet, W Brugger, et al. (2002) German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma. Ann Neurol 51 247-252.
150. A Nicolato, MA Gerosa, R Foroni, et al. (1995) Gamma knife radiosurgery in AIDS-related primary central nervous system lymphoma. Stereotact Funct Neurosurg 64 42-55.
151. AJ Ferreri, LE Abrey, JY Blay, et al. (2002) Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002. J Clin Ooncol 21 2407-2414.
152. Y Kawakami, K Tabuchi, R Ohnishi, et al. (1985) Primary central nervous system lymphoma. J Neurosurg 62 522-527.
153. CR Freeman, C Shustik, ML Brisson, et al. (1986) I. Primary malignant lymphoma of the central nervous system. Cancer 58 1106-1111.
154. NP Mendenhall, TL Thar, OF Agee, et al. (1983) Primary lymphoma of the central nervous system: computerized tomography scan characteristics and treatment results for 12 cases. Cancer 52 1993-2000.
155. DG Gonzalez and AL Schuster-Uitterhoeve (1983) Primary non-Hodgkin's lymphoma of the central nervous system. Cancer 51 2048-2052.
156. JW Grant, PJ Gallagher and DB Jones (1986) Primary cerebral lymphoma. Arch Pathol Lab Med 110 897-901.
157. K Murray, L Kun and J Cox (1986) Primary malignant lymphoma of the central nervous system. J Neurosurg 65 600-607.
158. A Di Marco, L Rosta, F Campostrini, et al. (1986) The role of radiation therapy in the management of primary non-Hodgkin's lymphomas of the central nervous system: clinical study of 10 cases. Tumori 72 565-573.
159. DE Hobson, BA Anderson, I Carr, et al. (1986) Primary lymphoma of the central nervous system: Manitoba experience and literature review. Can J Neurol Sci 13 55-61.
160. C Bertoncelli, P Zigrossi, M Campanini, et al. (1987) Primary lymphoma of the central nervous system. A clinical and immunohistological study of 8 patients. Haematologica 72 137-142.
161. IF Pollack, LD Lunsford, JC Flickinger, et al. (1989) Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma. Cancer 63 939-947.
162. P McLaughlin, WS Velasquez, JR Redman, et al. (1988) Chemotherapy with dexamethasone, high-dose cytarabine, and cisplatin for parenchymal brain lymphomas. J Natl Cancer Inst 80 1408-1412.
163. A Allegranza, C Mariani, R Giardini, et al. (1984) Primary malignant lymphomas of the central nervous system: a histological and immunohistological study of 12 cases. Histopathology 8 781-791.
164. DJ Stewart, N Russell, EA Atack, et al. (1983) Cyclophosphamide, doxorubicin, vincristine, and dexamethasone in primary lymphoma of the brain: a case report. Cancer Treat Rep 67 287-291.
165. IJ Cohen, R Vogel, S Matz, et al. (1986) Successful non-neurotoxic therapy [without radiation] of a multi-focal primary brain lymphoma with a methotrexate, vincristine, and BCNU protocol [DEMOB]. Cancer 57 6-11.
166. ST Vakili, J Muller, H Shidnia, et al. (1986) Primary lymphoma of the central nervous system: a clinico-pathologic analysis of 26 cases. J Surg Oncol 33 95-102.
167. D Schiffer, A Chio, MT Giordana, et al. (1987) Primary lymphomas of the brain: a clinicopathologic review of 37 cases. Tumori 73 585-592.
168. JS Loeffler, TJ Ervin, P Mauch, et al. (1985) Primary lymphomas of the central nervous system: Patterns of failure and factors that influence survival. J Clin Oncol 3 490-494.
169. T Yasunaga, M Takahashi, H Uozumi, et al. (1986) Radiation therapy of primary malignant lymphoma of the brain. Acta Radiol Oncol 25 23-28.
170. R Woodman, K Shin and G Pineo (1985) Primary non-Hodgkin's lymphoma of the brain. Medicine (Baltimore) 64 425-430.
171. JM Michalski, DM Garcia, E Kase, et al. (1990) Primary central nervous system lymphoma: analysis of prognostic variables and patterns of treatment failure. Radiology 176 855-860.
172. K Pittman, CL Olweny, JB North, et al. (1991) Primary central nervous system lymphoma. Oncology 48 184-187.
173. EA Neuwelt, DL Goldman, SA Dahlborg, et al. (1991) Primary CNS lymphoma treated with osmotic blood brain barrier disruption: prolonged survival and presentation of cognitive function. J Clin Oncol 9 1580-1590.
174. FH Rampen, JG van Andel, W Sizoo, et al. (1980) Radiation therapy in primary non-Hodgkin's lymphomas of the CSN. Eur J Cancer 16 177-184.
175. MP Berry and WJ Simpson (1981) Radiation therapy in the management of primary malignant lymphoma of the brain. Int J Radiat Oncol Biol Phys 7 55-59.
176. JA Spillane, BE Kendall and IF Moseley (1982) Cerebral lymphoma: clinical radiological correlation. J Neurol Neurosurg Psychiatry 45 199-208.
177. KH Merkel and ML Hansmann (1986) Primary non-Hodgkin's lymphomas of the central nervous system. Pathol Res Pract 181 430-433.
178. M Watanabe, R Tanaka, N Takeda, et al. (1992) Correlation of computed tomography with the histopathology of the primary malignant lymphoma of the brain. Neuroradiology 34 36-42.
179. U Bogdahn, S Bogdahn, HG Mertens, et al. (1986) Primary non-Hodgkin's lymphomas of the CNS. Acta Neurol Scand 73 602-614.
180. RH Sagerman, CH Collier and GA King (1983) Radiation therapy of microgliomas. Radiology 149 567-570.
181. TL Helle, RH Britt and TV Colby (1984) Primary lymphoma of the central nervous system. Clinicopathological study of experience at Stanford. J Neurosurg 60 94-103.
182. G Frank, R Ferracini, F Spagnolli, et al. (1985) Primary intracranial lymphomas. Surg Neurol 23 3-8.
183. E Spaun, S Midholm, NT Pederson, et al. (1985) Primary malignant lymphoma of the central nervous system. Surg Neurol 24 646-650.
184. SC Remick, C Diamond, JA Migliozzi, et al. (1990) Primary central nervous system lymphoma in patients with and without the acquired immune deficiency syndrome. Medicine (Baltimore) 69 345-360.
185. GP Casadei and M Gambacorta (1985) A clinicopathological study of seven cases of primary high-grade malignant non-Hodgkin's lymphoma of the central nervous system. Tumori 71 501-507.
186. YT So, JH Beckstead and RL Davis (1986) Primary central nervous system lymphoma in acquired immune deficiency syndrome: a clinical and pathological study. Ann Neurol 20 566-572.
187. T Poon, I Matoso, V Tchertkoff, et al. (1989) CT features of primary cerebral lymphoma in AIDS and non-AIDS patients. J Comput Assist Tomogr 13 6-9.
188. SC Formenti, PS Gill, E Lean, et al. (1989) Primary central nervous system lymphoma in AIDS. Cancer 63 1101-1107.
189. C Loureiro, PS Gill, PR Meyer, et al. (1988) Autopsy findings in AIDS-related lymphoma. Cancer 62 735-739.
190. AM Levine, J Sullivan-Halley, MC Pike, et al. (1991) Human immunodeficiency virus-related lymphoma. Cancer 68 2466-2472.
191. EM MacMahon, JD Glass, SD Hayward, et al. (1991) Epstein–Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 338 969-973.
192. JD Goldstein, B Zeifer, C Chao, et al. (1991) CT appearance of primary CNS lymphoma in patients with acquired immunodeficiency syndrome. J Comput Assist Tomogr 15 39-44.
193. TS Dina (1991) Primary central nervous system lymphoma versus toxoplasmosis in AIDS. Radiology 179 823-828.
194. JE Baumgartner, JR Rachlin, JH Beckstead, et al. (1990) Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immune deficiency syndrome. J Neurosurg 73 206-211.
195. ET Chappell, BL Guthrie and J Orenstein (1992) The role of stereotactic biopsy in the management of HIV-related focal brain lesions. Neurosurgery 30 825-829.
196. JD Goldstein, DW Dickson, FG Moser, et al. (1991) Primary central nervous system lymphoma in acquired immune deficiency syndrome. Cancer 67 2756-2765.
197. JL Ziegler, JA Beckstead, PA Volberding, et al. (1984) Non-Hodgkin's lymphoma in 90 homosexual men. N Engl J Med 311 565-570.
198. EF DiCarlo, JB Amberson, CE Metroka, et al. (1986) Malignant lymphomas and the acquired immunodeficiency syndrome. Arch Pathol Lab Med 110 1012-1016.
199. RE Nakhleh, JC Manivel, D Hurd, et al. (1989) Central nervous system lymphomas. Arch Pathol Lab Med 113 1050-1056.
200. SD Pitlik, V Fainstein, R Bolivar, et al. (1983) Spectrum of central nervous system complications in homosexual men with acquired immune deficiency syndrome [Letter]. J Infect Dis 148 771-772.
201. Italian Cooperative Group for AIDS-Related Tumors. (1988) Malignant lymphomas in patients with or at risk for AIDS in Italy. J Natl Cancer Inst 80 855-860.
202. JC McArthur (1987) Neurologic manifestations of AIDS. Medicine (Baltimore) 66 407-437.
203. AH Capanna, JJ LaMancusa, F Erculei, et al. (1987) Primary cerebral lymphoma in two consortial partners afflicted with acquired immune deficiency syndrome. Neurosurgery 21 920-923.
204. MH Mernick, SC Malamud, A Haubenstock, et al. (1986) Non-Hodgkin's lymphoma in AIDS: report of 11 cases and literature review. Mt Sinai J Med 53 664-667.
205. RB Snow and MH Lavyne (1985) Intracranial space-occupying lesions in acquired immune deficiency syndrome patients. Neurosurgery 16 148-153.
206. BS Koppel, GP Wormser, AJ Tuchman, et al. (1985) Central nervous system involvement in patients with acquired immune deficiency syndrome (AIDS). Acta Neurol Scand 71 337-353.
207. PS Gill, AM Levine, PR Meyer, et al. (1985) Primary central nervous system lymphoma in homosexual men. Clinical, immunologic, and pathologic features. Am J Med 78 742-748.
208. KH Anders, H Latta, BS Chang, et al. (1989) Lymphomatoid granulomatosis and malignant lymphoma of the central nervous system in the acquired immunodeficiency syndrome. Hum Pathol 20 326-334.
209. MH Kaplan, M Susin, SG Pahwa, et al. (1987) Neoplastic complications of HTLV-III infection. Am J Med 82 389-396.
210. SP Kalter, SA Riggs, F Cabanillas, et al. (1985) Aggressive non-Hodgkin's lymphoma in immunocompromised homosexual males. Blood 66 655-659.
211. DA Lowenthal, DJ Straus, SW Campbell, et al. (1988) AIDS-related lymphoid neoplasia: the Memorial Hospital experience. Cancer 61 2325-2337.
212. T Ahmed, GP Wormser, RE Stahl, et al. (1987) Malignant lymphomas in a population at risk for acquired immune deficiency syndrome. Cancer 60 719-723.
213. DM Knowles, GA Chamulak, M Subar, et al. (1988) Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 108 744-753.
214. LD Kaplan, DI Abrams, AL Feigal, et al. (1989) AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA 261 719-724.
215. SK Song, IS Schwartz and BA Breakstone (1986) Lymphoproliferative disorder of the central nervous system in AIDS. Mt Sinai J Med 53 686-689.
216. DH Gabuzda and MS Hirsch (1987) Neurologic manifestations of infection with human immunodeficiency virus. Clinical features and pathogenesis. Ann Intern Med 107 383-391.
217. RE Appen (1975) Posterior uveitis and primary cerebral reticulum cell sarcoma. Arch Ophthalmol 93 123-124.
218. DH Char, B-M Ljung, T Miller, et al. (1988) Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management. Ophthalmology 95 625-630.
219. EJ Rockwood, ZN Zakov and JW Bay (1984) Combined malignant lymphoma of the eye and CNS (reticulum-cell sarcoma). J Neurosurg 61 369-374.
220. DB Duggan, GD Ehrlich, FP Davey, et al. (1988) HTLV-I-induced lymphoma mimicking Hodgkin's disease: Diagnosis by polymerase chain reaction amplification of specific HTLV-1 sequences in tumor DNA. Blood 71 1027-1032.
221. C Ezrin-Waters, M Klein, J Deck, et al. (1984) Diagnostic importance of immunological markers in lymphoma involving the central nervous system. Ann Neurol 16 668-672.
222. GR Jones, WH Mason, LS Fishman, et al. (1985) Primary central nervous system lymphoma without intracranial mass in a child. Diagnosis by documentation of monoclonality. Cancer 56 2804-2808.
223. KH Anders, WF Guerra, U Tomiyasu, et al. (1986) The neuropathology of AIDS. Am J Pathol 124 537-558.
224. BJ Luft, R Hafner, AH Korzun, et al. (1993) Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome: Members of the ACTG 077p/ANRS 009 Study Team. N Engl J Med 329 995-1000.
225. JM Hoffman, HA Waskin, T Schifter, et al. (1993) FDG-PET in determining lymphoma from nonmalignant central nervous system lesions in patients with AIDS. J Nucl Med 34 567-575.
226. JM Henry, RR Heffner, SH Dillard, et al. (1974) Primary malignant lymphomas of the central nervous system. Cancer 34 1293-1302.
227. RH Sagerman, JR Cassady and CH Chang (1967) Radiation therapy for intracranial lymphoma. Radiology 88 552-554.
228. DF Nelson, KL Martz, H Bonner, et al. (1992) Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 83–15. Int J Radiat Oncol Biol Phys 23 9-17.
229. T Tatsuta, M Naito, T Oh-hara, et al. (1992) Functional involvement of P-glycoprotein in blood-brain barrier. J Biol Chem 267 20383-20391.
230. WR Shapiro and DF Young (1984) Neurologic complications of antineoplastic therapy. Acta Neurol Scand 70 125-132.
231. CS Kretschmar, MP Warren, BL Lavally, et al. (1990) Ototoxicity of pre-radiation cisplatin for children with central nervous system tumors. J Clin Oncol 8 1191-1198.
232. AA Gabbai, FH Hochberg, RM Linggood, et al. (1989) High-dose methotrexate for non-AIDS primary central system lymphoma. J Neurosurg 70 190-194.
233. C Schultz, CTW Scott, B Fisher, et al. (1994) Pre-irradiation chemotherapy (CTX) with cytoxan, adriamycin, vincristine, and decadron (CHOD) for primary central nervous system lymphoma (PCNSL): initial report of Radiation Therapy Oncology Group (RTOG) protocol 88–06. Proc ASCO 485 174.
234. ME Newell, JF Hoy, SG Cooper, et al. (2004) Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients. Cancer 100 2627-2636.